MASTERS CAPITAL MANAGEMENT LLC 13D and 13G filings for Virios Therapeutics, Inc.:
- Schedule 13D must be filed within ten days after a person or an organization acquires beneficial ownership of more than 5% of a voting class of a company's equity securities.
- Shares have been adjusted for stock splits.
Reported DateTime |
Transaction Date |
Type | Company Symbol |
Filed By Symbol |
Shares Owned % Owned |
Shares Vs. Prev Report | View |
2023-02-14 08:08 am Sale |
2022-12-31 | 13G | Virios Therapeutics, Inc. VIRI |
MASTERS CAPITAL MANAGEMENT LLC | 0 0.000% |
-700,000![]() (Position Closed) |
Filing |
2022-02-11 9:35 pm Purchase |
2021-12-31 | 13G | Virios Therapeutics, Inc. VIRI |
MASTERS CAPITAL MANAGEMENT LLC | 700,000 8.400% |
252,043![]() (+56.26%) |
Filing |
2021-02-16 4:13 pm Purchase |
2020-12-31 | 13G | Virios Therapeutics, Inc. VIRI |
MASTERS CAPITAL MANAGEMENT LLC | 447,957 5.410% |
447,957![]() (New Position) |
Filing |